HIGHLIGHTS
- who: Melisa Pasli and collaborators from the Brody School of Medicine at East Carolina University, Greenville, NC, USA have published the paper: Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy, in the Journal: (JOURNAL)
- what: This study presents the greatest ratio of black patients, and is the first study focusing on racial disparities in advanced stage NSCLC patients regarding time-totreatment initiation (TTI). The study showed no difference in median PFS (6.22 months versus 5.49 months; log-rank p=0.725) and OS (11.61 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.